Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jimish Mehta"'
Autor:
Zahil Shanis, Harshith Padigela, Kathleen Sucipto, John Shamshoian, Jin Li, Andrew Walker, Darren Fahy, Mary Lin, Mike Montalto, Andrew Beck, Jimish Mehta, Ilan Wapinski, Archit Khosla, Harsha Pokkalla, Fedaa Najdawi, Christina Jayson
Publikováno v:
Inflammatory Bowel Diseases. 29:S19-S20
BACKGROUND Histology is emerging as a key therapeutic endpoint for ulcerative colitis driven by associations between histologic response and long-term outcomes. However, existing scoring systems are subjective and consequently have variable inter- an
Autor:
Iñigo Prieto Pradera, Jimish Mehta, Jonathan Boshard Ferron Olson, Lina Marcela Coy, Vadim Sapiro, Benjamin J. Park, Lauren N Hunt, Alex Saeed, Christian Pallares Gutiérrez, Jorge A Cano, Paul Malpiedi, Ayleen D Rivera, William J. Ketcherside, María Virginia Villegas Botero
Publikováno v:
Int J Infect Control
Infection control and antimicrobial stewardship programs (ICASPs) are essential to reduce the emergence and spread of antimicrobial resistance. The primary objective of this study was to assess the feasibility of extending a commercial off-the-shelf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc10a6b827895361947a6c87abcef88
https://europepmc.org/articles/PMC8205444/
https://europepmc.org/articles/PMC8205444/
Autor:
Raymond Lamore Iii, Wei Hsiang Lin, Christo Cimino, Jimish Mehta, Amanda Binkley, Naasha J Talati
Publikováno v:
Open Forum Infectious Diseases
Background Adverse drug events are associated with an increase in hospital stay and cost. Risks from these events are minimized by adjusting a medication’s dose or frequency, and changes in renal function may necessitate adjustments. Currently, the
Autor:
Keith W Hamilton, Jimish Mehta, Brandon Palermo, Jonathan Boshard Ferron Olson, Lauren N Hunt, W Joseph Ketcherside
Publikováno v:
Open Forum Infectious Diseases
Background Prior authorization (PA) of antimicrobial agents is recommended by CDC as a core antimicrobial stewardship (AMS) intervention and has been a cornerstone of the Hospital of the University of Pennsylvania (HUP) AMS program since its inceptio
Autor:
Timothy Glen Gaulton, Jimish Mehta, Ebbing Lautenbach, David F. Gaieski, Knashawn H. Morales, Mark G. Weiner
Publikováno v:
Internal and Emergency Medicine. 9:213-221
Sepsis is a major cause of hospital admissions and mortality. Nevertheless, there are significant gaps in our knowledge of the epidemiology of sepsis in obese people, who now represent more than one-third of the population in the United States. The o
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Keith W Hamilton, Stephen Saw, Steven Morgan, Tiffany Lee, Melissa White, Jimish Mehta, Shawn Binkley, Shannon Overly
Publikováno v:
Open Forum Infectious Diseases
Background ILÚM Heath Solutions, an infectious diseases software platform, developed precision antibiotic therapy (PAT) software to guide selection of therapy using data science, patient-specific factors, as well as historical patient, pharmacy, and
Autor:
Theoklis E. Zaoutis, Rebekah W. Moehring, Lori A. Pollack, Arjun Srinivasan, David N. Schwartz, Bernard C. Camins, Jeffrey S. Gerber, Keith W Hamilton, Deverick J. Anderson, Ebbing Lautenbach, Michael S. Calderwood, Jimish Mehta, Jennifer H Han
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 60(8)
Antimicrobial stewardship is pivotal to improving patient outcomes, reducing adverse events, decreasing healthcare costs, and preventing further emergence of antimicrobial resistance. In an era in which antimicrobial resistance is increasing, judicio
Publikováno v:
Open Forum Infectious Diseases
Background Generating antibiograms has been standard practice in many hospitals for decades, and many guidelines recommend updating the data on a yearly basis. While effective at summarizing a hospital’s susceptibility data across all patients, lik
Publikováno v:
Open Forum Infectious Diseases. 4:S166-S166